Synthesis and Antiproliferative Activity of Hybrid Peptides for Ovarian and Prostate Cancer

[1]  E. Ruoslahti.  Tumor penetrating peptides for improved drug delivery , 2017, Advanced drug delivery reviews.

[2]  M. Gleave,et al.  Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality , 2017, Oncogene.

[3]  P. Wei,et al.  BCL6 is a negative prognostic factor and exhibits pro-oncogenic activity in ovarian cancer. , 2015, American journal of cancer research.

[4]  M. Friedlander,et al.  Survival of Australian women with invasive epithelial ovarian cancer: a population‐based study , 2014, The Medical journal of Australia.

[5]  Erkki Ruoslahti,et al.  An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability , 2014, Nature Communications.

[6]  T. Zhu,et al.  B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells , 2014, BMC Cancer.

[7]  Alexander D. MacKerell,et al.  A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters. , 2013, Cell reports.

[8]  R. Nussinov,et al.  Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor. , 2013, Journal of structural biology.

[9]  N. Lazarov,et al.  [Tumor size and prognosis for patients with epithelial ovarian carcinoma at early stage]. , 2013, Akusherstvo i ginekologiia.

[10]  E. Esplugues,et al.  Bcl6 expression specifies the T follicular helper cell program in vivo , 2012, The Journal of experimental medicine.

[11]  E. Ruoslahti,et al.  C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration , 2009, Proceedings of the National Academy of Sciences.

[12]  A. Melnick,et al.  A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. , 2009, Blood.

[13]  T. Joh,et al.  BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers , 2009, British Journal of Cancer.

[14]  A. Melnick,et al.  A peptomimetic inhibitor of BCL 6 with potent antilymphoma effects in vitro and in vivo , 2009 .

[15]  A. Melnick,et al.  BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells. , 2008, Blood cells, molecules & diseases.

[16]  R. Dalla‐Favera,et al.  Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells , 2007, Nature Immunology.

[17]  R. Green,et al.  Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR , 2007, Nature Immunology.

[18]  N. Matsumura,et al.  Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition. , 2007, Gynecologic oncology.

[19]  N. Zeleznik-Le,et al.  Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas , 2007, Proceedings of the National Academy of Sciences.

[20]  K. Basso,et al.  BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells , 2005, Nature Immunology.

[21]  Ryan T. Phan,et al.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells , 2004, Nature.

[22]  J. Licht,et al.  Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells , 2004, Nature Medicine.

[23]  K. Hruska,et al.  Protein transduction: unrestricted delivery into all cells? , 2000, Trends in cell biology.

[24]  F. Piehl,et al.  Expression of LAZ3/BCL6 in follicular center (FC) B cells of reactive lymph nodes and FC-derived non-Hodgkin lymphomas , 1997, Leukemia.

[25]  K. Offit,et al.  Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. , 1994, Blood.

[26]  S. Ruben,et al.  Structural and functional characterization of human immunodeficiency virus tat protein , 1989, Journal of virology.